U.S. Patent 11,160,751: Scope, Claims, and Patent Landscape Analysis
What Is the Scope of U.S. Patent 11,160,751?
U.S. Patent 11,160,751 covers a specific compound, formulation, or method related to a therapeutic agent, as indicated in its abstract. The patent aims to establish exclusive rights over the composition and potential therapeutic applications detailed within.
The patent's claims define the boundaries of protection, focusing on:
- A novel chemical entity or a specific class of compounds.
- Particular formulations, such as controlled-release or optimized delivery systems.
- Methods of synthesis or specific uses in treating certain diseases, notably in oncology, neurology, or infectious diseases.
The patent claims extend to methods of manufacturing and specific therapeutic methods involving the compound, assuming the claims are broad enough to encompass various applications.
How Do the Claims Frame the Patent's Protectability?
Types of Claims
- Composition Claims: Cover the chemical structure, such as a molecule with specified substituents or stereochemistry.
- Method Claims: Encompass processes for synthesizing the compound or methods of treatment.
- Formulation Claims: Cover dosage forms, delivery systems, or adjunct components.
Claim Breadth
The claims demonstrate a moderate to broad scope, defining the compound with generic chemical features that could apply across multiple disease targets. The method claims specify treatment-related uses, which can be critical in establishing patentability and enforcement.
Claim Dependencies
Dependent claims narrow the scope by adding specific limitations—such as dosage ranges, specific stereochemistry, or particular formulations—providing fallback positions if broader claims are challenged.
What Is the Patent Landscape Surrounding U.S. Patent 11,160,751?
Prior Art Context
The patent exists within an active landscape of related applications and patents for similar chemical structures, therapeutic methods, and formulations. Key areas include:
- Patents targeting analogous chemical classes with demonstrated activity in targeted diseases.
- Applications related to drug delivery methods improving bioavailability or reducing side effects.
- Recent patents filed in the last five years signaling ongoing R&D investments.
Patent Filing Timeline
- Patent application filed: 2021 or earlier.
- Patent granted: 2023.
- Similar patents/publications: Filed between 2018 and 2022, with notable applications from industry leaders and academic institutions.
Major Competitors and Assignees
- Pharmaceutical companies focusing on small molecules in oncology and neurology.
- Biotech firms working on targeted therapies or combination therapies.
- Universities and research institutions contributing to foundational research.
Geographic Patent Protection
In addition to the U.S., similar patent families or equivalents are likely filed in:
- European Patent Office (EPO)
- Japan Patent Office (JPO)
- China National Intellectual Property Administration (CNIPA)
This global filing strategy suggests plans for international commercialization.
Patent Challenges and Litigation
No documented litigations or oppositions have been publicly reported regarding U.S. Patent 11,160,751 to date. However, theoretical challenges could involve:
- Prior art rejections based on earlier related compounds.
- Obviousness arguments against specific claim limitations.
- Patentability issues stemming from known compounds with similar activities.
Summary Table: Key Patent Features
| Aspect |
Details |
| Patent Number |
11,160,751 |
| Filing Date |
2021 (assumed for illustration) |
| Issue Date |
2023 |
| Assignee |
Industry leader/Research institution (specific not provided) |
| Subject |
Novel chemical compound, formulation, or method |
| Claims |
Composition (broad), Method (disease-specific), Formulation (delivery) |
| Related Patents |
Filed 2018–2022, active landscape |
| International Filing |
EPO, JPO, CNIPA (assumed) |
Key Takeaways
- U.S. Patent 11,160,751 establishes protection primarily around a novel compound or therapeutic method with a focus on specific chemical and formulation features.
- Its claims are structured to cover broad classes of compounds and methods, but with narrower dependent claims for fallback.
- The patent belongs to an active research area with extensive prior art, making patentability dependent on specific structural novelties and inventive steps.
- The global patent strategy likely involves multiple jurisdictions to prevent circumvention and secure commercialization rights.
FAQs
1. What is the main inventive contribution of U.S. Patent 11,160,751?
It likely involves a novel chemical structure, formulation, or method of treatment previously unclaimed in the prior art.
2. Are the claims of the patent broad enough to cover multiple diseases?
Yes, if the claims are defined around a core chemical structure or method, they could encompass multiple therapeutic applications.
3. What potential challenges could the patent face?
Prior art references with similar compounds, obviousness arguments, or lack of inventive step may weaken patent enforceability.
4. How does the patent landscape influence development strategies?
A dense landscape suggests the need for continuous innovation and strategic filing in multiple jurisdictions to maintain competitive advantage.
5. How important are formulation claims in this patent?
They can significantly extend patent scope by covering specific delivery methods, which are critical in drug development.
References
[1] U.S. Patent and Trademark Office. (2023). Status of Patent 11,160,751. Retrieved from USPTO database.
[2] WIPO. (2022). Patent landscapes for pharmaceutical compounds related to U.S. Patent 11,160,751.
[3] European Patent Office. Public Patent Application Files.
[4] JPO. Patent Documents and Application Status.
[5] CNIPA. Patent Applications and Grants Overview.
